Brookfield Corp ON Buys New Stake in American Healthcare REIT, Inc. (NYSE:AHR)

Brookfield Corp ON acquired a new position in shares of American Healthcare REIT, Inc. (NYSE:AHR) in the 3rd quarter, HoldingsChannel reports. The fund acquired 439,598 shares of the company’s stock, valued at approximately $11,474,000.

Several other hedge funds also recently added to or reduced their stakes in the stock. Charles Schwab Investment Management Inc. boosted its holdings in shares of American Healthcare REIT by 118.4% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,907,986 shares of the company’s stock valued at $49,798,000 after buying an additional 1,034,365 shares in the last quarter. Manning & Napier Advisors LLC acquired a new position in American Healthcare REIT in the second quarter valued at $3,317,000. Foundations Investment Advisors LLC purchased a new position in shares of American Healthcare REIT during the third quarter worth about $568,000. Swiss National Bank grew its holdings in shares of American Healthcare REIT by 126.6% during the third quarter. Swiss National Bank now owns 291,400 shares of the company’s stock worth $7,606,000 after purchasing an additional 162,800 shares during the last quarter. Finally, Hilton Capital Management LLC acquired a new stake in shares of American Healthcare REIT during the third quarter worth about $4,777,000. 16.68% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on AHR shares. JMP Securities raised their target price on shares of American Healthcare REIT from $18.00 to $30.00 and gave the stock a “market outperform” rating in a research report on Friday, September 20th. Colliers Securities upgraded shares of American Healthcare REIT from a “hold” rating to a “moderate buy” rating in a research note on Sunday, October 13th. Royal Bank of Canada raised their price objective on shares of American Healthcare REIT from $28.00 to $30.00 and gave the company an “outperform” rating in a research report on Monday, November 18th. Morgan Stanley boosted their target price on American Healthcare REIT from $17.00 to $22.00 and gave the stock an “overweight” rating in a research report on Thursday, August 22nd. Finally, Bank of America lifted their price target on American Healthcare REIT from $27.00 to $31.00 and gave the company a “buy” rating in a research note on Tuesday, September 24th. One analyst has rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $25.13.

American Healthcare REIT Price Performance

AHR stock opened at $28.55 on Friday. American Healthcare REIT, Inc. has a 1 year low of $12.63 and a 1 year high of $29.99. The firm has a market cap of $4.37 billion and a P/E ratio of -59.48. The stock’s 50 day moving average price is $26.54 and its 200 day moving average price is $20.88. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.37 and a current ratio of 0.37.

American Healthcare REIT (NYSE:AHR) last announced its earnings results on Tuesday, November 12th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of $0.32 by ($0.35). The firm had revenue of $523.81 million during the quarter, compared to analyst estimates of $474.26 million. American Healthcare REIT had a negative net margin of 1.84% and a negative return on equity of 1.87%. American Healthcare REIT’s revenue for the quarter was up 12.8% on a year-over-year basis. On average, sell-side analysts expect that American Healthcare REIT, Inc. will post 1.42 earnings per share for the current fiscal year.

American Healthcare REIT Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.